BioCentury | Aug 15, 2011
Product Development

Powering down cancer

The cancer metabolism field has been heating up over the last five years, and now is beginning to produce some of the first data for compounds aimed at stunting aerobic glycolysis, the energy-generating process that...
BC Week In Review | Oct 4, 2010
Clinical News

Myrexis preclinical data

In mice bearing nicotinate phosphoribosyltransferase ( NAPRT1 )-deficient pancreatic tumors, 75 mg/kg oral MPC-9528 on days 1, 10 and 19 inhibited tumor growth by 53% on day 19 vs. vehicle-treated controls. Furthermore, co-administration of 200 mg/kg...
Items per page:
1 - 2 of 2